ArticleHeliyon2024

AXL inhibition prevents RPA2/CHK1-mediated homologous recombination to increase PARP inhibitor sensitivity in hepatocellular carcinoma.

Kai-Min Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.